160 related articles for article (PubMed ID: 7201947)
21. [The treatment of metastasising mammary carcinoma with drostanolone propionate (masterid) (author's transl)].
von Lieven H; Büll U
MMW Munch Med Wochenschr; 1974 Nov; 116(47):2043-6. PubMed ID: 4216810
[No Abstract] [Full Text] [Related]
22. Consolidative 32P after second-look laparotomy for ovarian carcinoma.
Condra KS; Mendenhall WM; Morgan LS; Marcus RB
Radiat Oncol Investig; 1998; 6(2):97-102. PubMed ID: 9572686
[TBL] [Abstract][Full Text] [Related]
23. Second-look laparotomy in ovarian cancer.
Creasman WT
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy in ovarian cancer.
Park TW; Kuhn WC
Expert Rev Anticancer Ther; 2004 Aug; 4(4):639-47. PubMed ID: 15270667
[TBL] [Abstract][Full Text] [Related]
25. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
26. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
28. Treatment of ovarian carcinoma. Surgical aspects.
Way S
Proc R Soc Med; 1969 Apr; 62(4):357-8. PubMed ID: 5811946
[No Abstract] [Full Text] [Related]
29. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
[TBL] [Abstract][Full Text] [Related]
30. [Is there a place for 2nd look laparotomy in the treatment of ovarian cancers?].
Stöckle E; Bussières E; Stöckle M; Avril A; Thomas L; Chauvergne J; Brunet R; Pigneux J; Marée D
Bull Cancer; 1993 Jul; 80(7):629-38. PubMed ID: 8204944
[TBL] [Abstract][Full Text] [Related]
31. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.
Helm CW; Bristow RE; Kusamura S; Baratti D; Deraco M
J Surg Oncol; 2008 Sep; 98(4):283-90. PubMed ID: 18726895
[TBL] [Abstract][Full Text] [Related]
32. Operation, external irradiation, radioactive isotopes, and chemotherapy in treatment of metastatic ovarian malignancies.
Villasanta U; Bloedorn FG
Am J Obstet Gynecol; 1968 Oct; 102(4):531-6. PubMed ID: 4176065
[No Abstract] [Full Text] [Related]
33. Second look laparotomy in the management of malignant epithelial ovarian neoplasias.
Facchini V; Gadducci A; Del Bravo B; Colombi L; Bartolini T; Manfredini C; Fioretti P
Eur J Gynaecol Oncol; 1986; 7(2):122-9. PubMed ID: 3459658
[TBL] [Abstract][Full Text] [Related]
34. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
Capretti PG; Zeppieri MC; Simonetti A; Rosato S; Lovotti D; Battaini A; Capretti G; Agnes Pradelli B
Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.
Kapp KS; Kapp DS; Poschauko J; Stücklschweiger GF; Hackl A; Pickel H; Petru E; Winter R
Gynecol Oncol; 1999 Sep; 74(3):400-7. PubMed ID: 10479500
[TBL] [Abstract][Full Text] [Related]
36. [Peritonectomy in the treatment of ovarian carcinoma at an advanced stage].
Zotti EF; Munegato G; Nicoletto O
G Chir; 1993 Feb; 14(2):75-8. PubMed ID: 8489897
[No Abstract] [Full Text] [Related]
37. Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure.
Goff BA; Ries JA; Els LP; Coltrera MD; Gown AM
Gynecol Oncol; 1998 Sep; 70(3):378-85. PubMed ID: 9790791
[TBL] [Abstract][Full Text] [Related]
38. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
39. Ovarian cancer and its treatment.
Grönroos M; Laurén P; Lehto J; Rauramo L
Ann Chir Gynaecol Fenn; 1969; 58(2):83-9. PubMed ID: 5363960
[No Abstract] [Full Text] [Related]
40. Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group.
Emons G; Ortmann O; Teichert HM; Fassl H; Löhrs U; Kullander S; Kauppila A; Ayalon D; Schally A; Oberheuser F
Cancer; 1996 Oct; 78(7):1452-60. PubMed ID: 8839551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
